000 | 00949 a2200265 4500 | ||
---|---|---|---|
005 | 20250513184159.0 | ||
264 | 0 | _c19990623 | |
008 | 199906s 0 0 eng d | ||
022 | _a0007-0912 | ||
024 | 7 |
_a10.1093/bja/82.2.299-a _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWoolf, R L | |
245 | 0 | 0 |
_aEarly clinical experience with a newly formulated hydroxyethyl starch--Hextend. _h[electronic resource] |
260 |
_bBritish journal of anaesthesia _cFeb 1999 |
||
300 |
_a299-300 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 |
_aHemodilution _xmethods |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroxyethyl Starch Derivatives _xtherapeutic use |
650 | 0 | 4 |
_aPlasma Substitutes _xtherapeutic use |
700 | 1 | _aChapman, M V | |
700 | 1 | _aMythen, M G | |
773 | 0 |
_tBritish journal of anaesthesia _gvol. 82 _gno. 2 _gp. 299-300 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/bja/82.2.299-a _zAvailable from publisher's website |
999 |
_c10323558 _d10323558 |